{"entity":{"id":"jeffrey-miller","kind":"person","name":"Jeffrey Miller","aka":[],"tldr":"Physician who directs the Masonic Cancer Center at the University of Minnesota, the NCI-designated comprehensive cancer centre in Minneapolis.","summary":"Jeffrey Miller, MD, is Director of the Masonic Cancer Center, University of Minnesota. The centre's leadership directory lists him at the head of a senior team that includes Deputy Director David Largaespada, PhD, and Executive Director and Associate Director of Administration Aaron Schilz, MPA, together with associate directors for translational research, clinical research, basic sciences, training and education, population sciences and data sciences. The directory page gives no appointment date or biography.","asOf":"2026-09-10","links":[{"label":"Source: Masonic Cancer Center leadership directory","url":"https://cancer.umn.edu/about/leadership"}],"tags":["leadership","clinician-scientist","comprehensive-cancer-centre"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["minnesota-masonic"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["blood-advances","blood"],"dependsOn":[],"notes":[],"role":"Director, Masonic Cancer Center, University of Minnesota","institutionId":"minnesota-masonic","specialisms":["Haematology and oncology","Cancer immunotherapy","Cancer centre leadership"],"profiles":[{"label":"Masonic Cancer Center leadership page","url":"https://cancer.umn.edu/about/leadership"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Miller+JS%5BAuthor%5D+AND+Minnesota"}],"papers":[{"title":"First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia","journal":"Blood Advances","year":2019,"doi":"10.1182/bloodadvances.2018028332"},{"title":"Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation","journal":"Blood","year":2018,"doi":"10.1182/blood-2017-08-752170"},{"title":"161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS","journal":"Blood Advances","year":2018,"doi":"10.1182/bloodadvances.2017012369"}]},"route":"/people/jeffrey-miller/","neighbours":{"institution":[{"id":"minnesota-masonic","kind":"institution","name":"Masonic Cancer Center, University of Minnesota","route":"/institutions/minnesota-masonic/"}],"journal":[{"id":"blood","kind":"journal","name":"Blood","route":"/journals/blood/"},{"id":"blood-advances","kind":"journal","name":"Blood Advances","route":"/journals/blood-advances/"}]}}